0001104659-20-061761.txt : 20200515 0001104659-20-061761.hdr.sgml : 20200515 20200514185602 ACCESSION NUMBER: 0001104659-20-061761 CONFORMED SUBMISSION TYPE: FWP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200515 DATE AS OF CHANGE: 20200514 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: FWP SEC ACT: 1934 Act SEC FILE NUMBER: 333-223095 FILM NUMBER: 20879842 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: FWP BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 FWP 1 a20-17830_3fwp.htm FWP

 

Filed Pursuant to Rule 433 under the Securities Act of 1933

Registration Statement No. 333-223095

Issuer Free Writing Prospectus, dated May 14, 2020

 

Boston Scientific Corporation

 

$1,700,000,000

Senior Notes Offering

 

Terms and Conditions — 5- and 10-Year Fixed Rate Notes

 

 

 

5-Year

 

10-Year

 

 

 

 

 

Issuer

 

Boston Scientific Corporation

 

Boston Scientific Corporation

 

 

 

 

 

Note Type

 

Senior Notes

 

Senior Notes

 

 

 

 

 

Form of Offering

 

SEC Registered

 

SEC Registered

 

 

 

 

 

Ratings(1)

 

Baa2/BBB-/BBB (Stable/Stable/Stable)

 

Baa2/BBB-/BBB (Stable/Stable/Stable)

 

 

 

 

 

Principal Amount

 

$500,000,000

 

$1,200,000,000

 

 

 

 

 

Trade Date

 

May 14, 2020

 

May 14, 2020

 

 

 

 

 

Settlement Date (T+2)

 

May 18, 2020

 

May 18, 2020

 

 

 

 

 

Maturity Date

 

June 1, 2025

 

June 1, 2030

 

 

 

 

 

Coupon

 

1.900% per annum

 

2.650% per annum

 

 

 

 

 

Yield to Maturity

 

1.910% per annum

 

2.667% per annum

 

 

 

 

 

Price to Public

 

99.952%

 

99.851%

 

 

 

 

 

Spread to Benchmark Treasury

 

Plus 160 basis points

 

Plus 205 basis points

 

 

 

 

 

Benchmark Treasury

 

0.375% UST due April 30, 2025

 

1.500% UST due February 15, 2030

 

 

 

 

 

Benchmark Treasury Yield

 

0.310%

 

0.617%

 

 

 

 

 

Benchmark Treasury Price

 

100-10 ¼

 

108-11

 

 

 

 

 

Interest Payment Dates

 

Semi-annually on June 1 and December 1

 

Semi-annually on June 1 and December 1

 

 

 

 

 

First Interest Payment Date

 

December 1, 2020

 

December 1, 2020

 

 

 

 

 

Make-whole Call

 

Prior to May 1, 2025, make-whole call at T+25 basis points

 

Prior to March 1, 2030, make-whole call at T+35 basis points

 

 

 

 

 

Par Call

 

On or after May 1, 2025

 

On or after March 1, 2030

 

 

 

 

 

Change of Control Repurchase Event

 

Putable at 101% of aggregate principal amount plus accrued and unpaid interest, if any, to, but not including, the date of repurchase

 

Putable at 101% of aggregate principal amount plus accrued and unpaid interest, if any, to, but not including, the date of repurchase

 

 

 

 

 

Day Count Basis

 

30/360

 

30/360

 

 

 

 

5-Year

 

10-Year

 

 

 

 

 

Minimum Denominations

 

$2,000 and integral multiples of $1,000 in excess of such amount

 

$2,000 and integral multiples of $1,000 in excess of such amount

 

 

 

 

 

CUSIP / ISIN

 

101137 AZ0 / US101137AZ01

 

101137 BA4 / US101137BA41

 

 

 

 

 

Joint Bookrunners

 

Barclays Capital Inc.

Citigroup Global Markets Inc.

J.P. Morgan Securities LLC

Wells Fargo Securities, LLC

BofA Securities Inc.

DNB Markets, Inc.

RBC Capital Markets, LLC

Scotia Capital (USA) Inc.

SG Americas Securities, LLC

 

Barclays Capital Inc.

Citigroup Global Markets Inc.

J.P. Morgan Securities LLC

Wells Fargo Securities, LLC

BofA Securities Inc.

DNB Markets, Inc.

RBC Capital Markets, LLC

Scotia Capital (USA) Inc.

SG Americas Securities, LLC

 

 

 

 

 

Co-Managers

 

Allied Irish Banks p.l.c.

BNP Paribas Securities Corp.

Goldman Sachs & Co. LLC

MUFG Securities Americas Inc.

Standard Chartered Bank

TD Securities (USA) LLC

U.S. Bancorp Investments, Inc.

 

Allied Irish Banks p.l.c.

BNP Paribas Securities Corp.

Goldman Sachs & Co. LLC

MUFG Securities Americas Inc.

Standard Chartered Bank

TD Securities (USA) LLC

U.S. Bancorp Investments, Inc.

 

Note:

 

(1)                     A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

 

The Issuer has filed a registration statement (including a preliminary prospectus supplement and accompanying prospectus) with the U.S. Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates.  Before you invest, you should read the preliminary prospectus supplement and accompanying prospectus and other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering.  You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov.  Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the preliminary prospectus supplement and accompanying prospectus if you request it by calling Barclays Capital Inc. toll-free at (888) 603-5847, Citigroup Global Markets Inc. toll-free at (800) 831-9146, J.P. Morgan Securities LLC collect at (212) 834-4533 or Wells Fargo Securities, LLC toll-free at (800) 645-3751.

 

Any disclaimers or other notices that may appear below are not applicable to this communication and should be disregarded.  Such disclaimers or other notices were automatically generated as a result of this communication being sent via Bloomberg or another email system.